Top

Published in:

01-03-2018 | Original Article

Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study

Authors: Mami Ogita, Naomi Nagura, Jiro Kawamori, Reika In, Atsushi Yoshida, Hideko Yamauchi, Junko Takei, Naoki Hayashi, Yoshiko Iwahira, Sachiko Ohde, Shoko Fukushima, Kenji Sekiguchi

Published in: Breast Cancer | Issue 2/2018

Abstract

Background

The use of post-mastectomy radiotherapy (PMRT) following immediate breast reconstruction has increased recently, and its safety is becoming a major concern. We aimed to evaluate the complication rates of PMRT to immediate tissue-expander/permanent implant (TE/PI)-based reconstructions for breast cancer and its association with radiotherapy timing (irradiation to TE or PI).

Methods

We retrospectively reviewed the cases of breast cancer patients who underwent mastectomy, immediate TE/PI reconstruction, and PMRT between January 2003 and December 2014. The rates of complications including reconstruction failure, re-operation, and infection were estimated by Kaplan–Meier analysis. The risk factors including radiotherapy timing were analyzed by log-rank test and multivariate Cox proportional hazard model.

Results

A total of 81 patients were included. Median follow-up was 32 months (range 2–120 months). Radiotherapy consisted of 50 Gy to the reconstructed breast and supraclavicular region in most cases. Total reconstruction failure, re-operation, and infection rates were 12.3, 13.6, and 11.1%, and 5-year cumulative reconstruction failure, re-operation, and infection rates were 16.7, 16.6, and 12.2%, respectively. No significant differences were observed in complication rates with respect to radiotherapy timing. In multivariate analysis, age 55 years and older was a significant risk factor for complications (P < 0.05).

Conclusion

There were no significant differences in rates of reconstruction failure, re-operation, or infection with regard to radiotherapy timing. PMRT to reconstructed breasts of older patients aged 55 years or over can be expected to result in more complications than in younger patients.

Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150:9–16.CrossRefPubMed

Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014;32:919–26.CrossRefPubMedPubMedCentral

Kurebayashi J, Miyoshi Y, Ishikawa T, Saji S, Sugie T, Suzuki T, et al. Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011. Breast Cancer. 2015;22:235–44.CrossRefPubMed

Reefy S, Patani N, Anderson A, Burgoyne G, Osman H, Mokbel K. Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction: a prospective observational study. BMC Cancer. 2010;10:171.CrossRefPubMedPubMedCentral

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRefPubMed

EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.CrossRef

Network NCC. NCCN Web site. NCCN Practice Guidelines in Oncology—v.2.2017: Breast cancer. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 16 June 2017.

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8–30.CrossRefPubMed

Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, et al. Temporal trends in postmastectomy radiation therapy and breast reconstruction associated with changes in national comprehensive cancer network guidelines. JAMA Oncol. 2015;2:1–7.

10.

Barry M, Kell MR. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat. 2011;127:15–22.CrossRefPubMed

11.

Lam TC, Hsieh F, Boyages J. The effects of postmastectomy adjuvant radiotherapy on immediate two-stage prosthetic breast reconstruction: a systematic review. Plast Reconstr Surg. 2013;132:511–8.CrossRefPubMed

12.

Cordeiro PG, Albornoz CR, McCormick B, Hudis CA, Hu Q, Heerdt A, et al. What is the optimum timing of postmastectomy radiotherapy in two-stage prosthetic reconstruction: radiation to the tissue expander or permanent implant? Plast Reconstr Surg. 2015;135:1509–17.CrossRefPubMedPubMedCentral

13.

Lentz R, Ng R, Higgins SA, Fusi S, Matthew M, Kwei SL. Radiation therapy and expander-implant breast reconstruction: an analysis of timing and comparison of complications. Ann Plast Surg. 2013;71:269–73.CrossRefPubMed

14.

Center for disease control and prevention. CDC/NHSN surveillance definitions for specific types of infections. January 2017. Available at: http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed 15 June 2017.

15.

Nava MB, Pennati AE, Lozza L, Spano A, Zambetti M, Catanuto G. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg. 2011;128:353–9.CrossRefPubMed

16.

Baschnagel AM, Shah C, Wilkinson JB, Dekhne N, Arthur DW, Vicini FA. Failure rate and cosmesis of immediate tissue expander/implant breast reconstruction after postmastectomy irradiation. Clin Breast Cancer. 2012;12:428–32.CrossRefPubMed

17.

Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, et al. Rates of reconstruction failure in patients undergoing immediate reconstruction with tissue expanders and/or implants and postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:634–41.CrossRefPubMed

18.

McCarthy CM, Mehrara BJ, Riedel E, Davidge K, Hinson A, Disa JJ, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008;121:1886–92.CrossRefPubMed

19.

Fischer JP, Nelson JA, Serletti JM, Wu LC. Peri-operative risk factors associated with early tissue expander (TE) loss following immediate breast reconstruction (IBR): a review of 9305 patients from the 2005–2010 ACS-NSQIP datasets. J Plast Reconstr Aesthet Surg. 2013;66:1504–12.CrossRefPubMed

20.

Berry T, Brooks S, Sydow N, Djohan R, Nutter B, Lyons J, et al. Complication rates of radiation on tissue expander and autologous tissue breast reconstruction. Ann Surg Oncol. 2010;17(Suppl 3):202–10.CrossRefPubMed

21.

Brooks S, Djohan R, Tendulkar R, Nutter B, Lyons J, Dietz J. Risk factors for complications of radiation therapy on tissue expander breast reconstructions. Breast J. 2012;18:28–34.CrossRefPubMed

22.

Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34:2308–24.CrossRefPubMedPubMedCentral

23.

Santosa KB, Chen X, Qi J, Ballard TN, Kim HM, Hamill JB, et al. Postmastectomy radiation therapy and two-stage implant-based breast reconstruction: is there a better time to irradiate? Plast Reconstr Surg. 2016;138:761–9.CrossRefPubMedPubMedCentral

24.

Anderson PR, Freedman G, Nicolaou N, Sharma N, Li T, Topham N, et al. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant—Is there a difference in complication rates? Int J Radiat Oncol Biol Phys. 2009;74:81–5.CrossRefPubMed

25.

Collier P, Williams J, Edhayan G, Kanneganti K, Edhayan E. The effect of timing of postmastectomy radiation on implant-based breast reconstruction: a retrospective comparison of complication outcomes. Am J Surg. 2014;207:408–11.CrossRefPubMed

26.

Yan C, Fischer JP, Freedman GM, Basta MN, Kovach SJ, Serletti JM, et al. The timing of breast irradiation in two-stage expander/implant breast reconstruction. Breast J. 2016;22:322–9.CrossRefPubMed

27.

Langstein HN, Cheng MH, Singletary SE, Robb GL, Hoy E, Smith TL, et al. Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg. 2003;111:712–20.CrossRefPubMed

28.

Stralman K, Mollerup CL, Kristoffersen US, Elberg JJ. Long-term outcome after mastectomy with immediate breast reconstruction. Acta Oncol. 2008;47:704–8.CrossRefPubMed

29.

Medina-Franco H, Vasconez LO, Fix RJ, Heslin MJ, Beenken SW, Bland KI, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg. 2002;235:814–9.CrossRefPubMedPubMedCentral

30.

Nedumpara T, Jonker L, Williams MR. Impact of immediate breast reconstruction on breast cancer recurrence and survival. Breast. 2011;20:437–43.CrossRefPubMed

31.

Gieni M, Avram R, Dickson L, Farrokhyar F, Lovrics P, Faidi S, et al. Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: a meta-analysis. Breast. 2012;21:230–6.CrossRefPubMed

32.

Damast S, Beal K, Ballangrud A, Losasso TJ, Cordeiro PG, Disa JJ, et al. Do metallic ports in tissue expanders affect postmastectomy radiation delivery? Int J Radiat Oncol Biol Phys. 2006;66:305–10.CrossRefPubMed

33.

Chen SA, Ogunleye T, Dhabbaan A, Huang EH, Losken A, Gabram S, et al. Impact of internal metallic ports in temporary tissue expanders on postmastectomy radiation dose distribution. Int J Radiat Oncol Biol Phys. 2013;85:630–5.CrossRefPubMed

34.

Vu TT, Pignol JP, Rakovitch E, Spayne J, Paszat L. Variability in radiation oncologists’ opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey. Clin Oncol (R Coll Radiol). 2007;19:115–9.CrossRef

35.

Thomas K, Rahimi A, Spangler A, Anderson J, Garwood D. Radiation practice patterns among United States radiation oncologists for postmastectomy breast reconstruction and oncoplastic breast reduction. Pract Radiat Oncol. 2014;4:466–71.CrossRefPubMed

36.

Chen SA, Hiley C, Nickleach D, Petsuksiri J, Andic F, Riesterer O, et al. Breast reconstruction and post-mastectomy radiation practice. Radiat Oncol. 2013;8:45.CrossRefPubMedPubMedCentral

Title: Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study
Authors: Mami Ogita
Naomi Nagura
Jiro Kawamori
Reika In
Atsushi Yoshida
Hideko Yamauchi
Junko Takei
Naoki Hayashi
Yoshiko Iwahira
Sachiko Ohde
Shoko Fukushima
Kenji Sekiguchi
Publication date: 01-03-2018
Publisher: Springer Japan
Published in: Breast Cancer / Issue 2/2018
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-017-0808-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2018

Candidate miRNAs in human breast cancer biomarkers: a systematic review

Trends in the clinical stage distribution of breast cancer in Osaka, Japan

Correction to: A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women

Margin-free excision of small solid breast carcinomas using the Intact Breast Lesion Excision System®: is it feasible?

Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case–control study

UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer